Genomic Valley Biotech Ltd - Stock Valuation and Financial Performance

BSE: 539206 | NSE: | Agriculture | Small Cap

Genomic Valley Share Price

82.20 2.60 3.27%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Genomic Valley

M-Cap below 100cr DeciZen not available

Genomic Valley Biotech stock performance -

mw4me loader
P/E Ratio (SA):
98.85
Market Cap:
25.1 Cr.
52-wk low:
26.2
52-wk high:
108.2

Is Genomic Valley Biotech Ltd an attractive stock to invest in?

1. Is Genomic Valley Biotech Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Genomic Valley Biotech Ltd is a below average quality company.

2. Is Genomic Valley Biotech Ltd undervalued or overvalued?

The key valuation ratios of Genomic Valley Biotech Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Genomic Valley Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Genomic Valley Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Genomic Valley:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Genomic Valley Biotech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 0.3%-6%-1.3%1.1%4.1%6.1%-5.1%0.9%20.4%0.5%-
Value Creation
Index
-1.0-1.4-1.1-0.9-0.7-0.6-1.4-0.90.5-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00.10.40.610.90.20.12.70.20
Sales YoY Gr.-266.7%300%34.1%67.8%-14.1%-75.3%-66.7%3,785.7%-93.8%-
Adj EPS -0.1-1.5-0.10.10.80.9-1.8-12.70.10.8
YoY Gr.-NANANA985.7%23.7%-294.7%NANA-98.2%-
BVPS (₹) 1614.914.714.815.616.514.79.411.611.612.5
Adj Net
Profit
0-0.5000.20.3-0.6-0.30.800
Cash Flow from Ops. 0.1-0.70.40.9-10.41.5-2.1-0.80-
Debt/CF from Ops. 8.2-1.12.20.9-1.43.41000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 21.3%-29.7%-6.8%-93.8%
Adj EPS NA-42%NA-98.2%
BVPS-3.5%-5.7%-7.6%0.4%
Share Price - - 54% 162.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-0.4-7.8-0.80.555.8-11.7-8.2260.46.9
Op. Profit
Mgn %
-149.5-406.6-6.517.542.265.4-65.6-534.832.49.373.3
Net Profit
Mgn %
-78.6-410.9-9.43.623.633.8-268.7-429.130.69.263.3
Debt to
Equity
0.20.20.20.20.30.30.30000
Working Cap
Days
30,5318,8832,0981,3828291,1323,6838,5144309,602344
Cash Conv.
Cycle
0025324058193144861,244306

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 6.90%

Sales growth is good in last 4 quarters at 39.59%

Sales growth has been subdued in last 3 years -6.80%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Genomic Valley Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 0.8 -
TTM Sales (₹ Cr.) 0.4 -
BVPS (₹.) 12.5 -
Reserves (₹ Cr.) 1 -
P/BV 6.58 -
PE 98.85 -
From the Market
52 Week Low / High (₹) 26.15 / 108.15
All Time Low / High (₹) 8.25 / 108.15
Market Cap (₹ Cr.) 25.1
Equity (₹ Cr.) 3.1
Face Value (₹) 10
Industry PE 42.2

Management X-Ray of Genomic Valley:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Genomic Valley

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0.030.110.440.590.990.850.210.072.720.17
Operating Expenses 0.080.550.540.490.570.290.340.451.840.15
Manufacturing Costs00.130.010.010.110.050.020.070.010
Material Costs0.010.070.100.050.05-0.070.0801.580
Employee Cost 0.030.130.250.340.270.180.090.140.150.04
Other Costs 0.040.220.190.100.150.130.160.230.100.11
Operating Profit -0.05-0.44-0.100.100.420.55-0.14-0.380.880.02
Operating Profit Margin (%) -149.0%-406.0%-23.2%17.0%42.2%65.4%-65.6%-534.0%32.4%9.3%
Other Income 0.070.160.080.010.010.0100.080.040
Interest 0.030.020000.180.180.0400
Depreciation 0.010.050.040.080.190.180.190.080.010
Exceptional Items 0000.020000.42-0.260
Profit Before Tax -0.01-0.34-0.070.060.230.21-0.5000.650.02
Tax 0-0.0100.020-0.080.060.0100
Profit After Tax -0.01-0.33-0.070.030.230.29-0.56-0.010.650.02
PAT Margin (%) -27.8%-307.0%-15.5%5.7%23.6%33.8%-268.0%-13.2%23.8%9.2%
Adjusted EPS (₹)0.0-1.1-0.20.10.80.9-1.80.02.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 5.925.584.494.534.765.054.492.883.533.54
Share Capital 3.053.053.053.053.053.053.053.053.053.05
Reserves 2.862.531.441.471.711.991.43-0.180.470.49
Minority Interest0000000000
Debt0.750.750.750.751.481.481.55000
Long Term Debt0.750.750.750.751.481.481.55000
Short Term Debt0000000000
Trade Payables000.010.0100.060.0400.610.60
Others Liabilities 0.790.720.761.390.931.351.540.920.280.19
Total Liabilities 7.467.066.026.677.187.947.613.804.424.33

Fixed Assets

Gross Block3.193.253.754.324.705.026.602.570.480
Accumulated Depreciation0.040.080.120.200.390.550.740.820.480
Net Fixed Assets3.153.183.634.124.314.475.861.7500
CWIP 0000.380.490.490.49000
Investments 0.550.1100000000.02
Inventories000.070.030.120.120000
Trade Receivables0000.020.060.100.0602.222.53
Cash Equivalents 0.170.010.050.010.080.040.0100.040.01
Others Assets3.593.762.262.112.132.721.192.042.161.78
Total Assets 7.467.066.026.677.187.947.613.804.424.33

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.09-0.690.350.87-1.040.441.48-2.13-0.78-0.02
PBT -0.01-0.34-0.070.060.230.21-0.50-0.420.910.02
Adjustment -0.03-0.11-0.030.040.180.180.19-0.26-0.030
Changes in Working Capital 0.13-0.230.450.77-1.450.061.8-1.45-1.66-0.03
Tax Paid 0000000000
Cash Flow From Investing Activity -0.650.53-0.31-0.910.37-0.47-1.583.671.52-0.02
Capex -0.14-0.08-0.5000.36-0.48-1.5801.480
Net Investments -0.550.440.11-0.940005.350-0.02
Others 0.040.160.080.030.0100-1.680.040
Cash Flow From Financing Activity 00000.7300.07-1.55-0.700
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 00000.7300.07-1.55-0.700
Net Cash Flow -0.56-0.160.04-0.040.06-0.04-0.03-0.010.04-0.04
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-0.17-7.08-1.510.765.015.83-11.73-0.2520.240.43
ROCE (%)0.34-5.99-1.311.124.126.1-5.140.9320.350.45
Asset Turnover Ratio00.020.070.090.140.110.030.010.660.04
PAT to CFO Conversion(x)N/AN/AN/A29-4.521.52N/AN/A-1.2-1
Working Capital Days
Receivable Days00014153514702975,249
Inventory Days00583228520000
Payable Days00197144-1832313,716700

Genomic Valley Biotech Ltd Stock News

Genomic Valley Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Genomic Valley on 20-Dec-2024 16:59 is ₹82.20.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Genomic Valley stood at ₹25.11.
The latest P/E ratio of Genomic Valley as of 20-Dec-2024 16:59 is 98.85.
The latest P/B ratio of Genomic Valley as of 20-Dec-2024 16:59 is 6.58.
The 52-week high of Genomic Valley is ₹108.2 and the 52-week low is ₹26.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Genomic Valley is ₹0.40 ( Cr.) .

About Genomic Valley Biotech Ltd

Genomic Valley Biotech Limited (GVBL) is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.

Currently, the company is engaged in providing consultancy in: a. High-Tech Cultivation through Environment Controlled Poly Houses, NFT & DFT etc; and b. Organic Farming --- Open Field Cultivation using Bio-Fertilizer. The company is also trading in agricultural and horticultural products.

Business area of the company 

The Company is providing consultancy in the Horticultural and Agricultural products. The company is also trading in Horticultural and Agricultural products.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.